Although our data suggest an active contribution of microglial cells in Cxcl16 production in AD, IHC analysis of the hippocampi from PLX5622-treated APP/PS1 animals revealed no changes in the recruitment of CD8+Cxcr6+ cells to the brain parenchyma. Here, CXCL16 is linked to Alzheimer disease.